Biodexa Pharmaceuticals (NASDAQ: BDRX)

Last close As at 21/12/2024

0.99

−0.03 (−2.94%)

Market capitalisation

5m

Edison Investment Research is terminating coverage on Biodexa Pharmaceuticals (BDRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More
Midatech Pharma_resized

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free